Glucose metabolic heterogeneity correlates with pathological features and improves survival stratification of resectable lung adenocarcinoma

MLA

Yu-Hung Chen, et al. “Glucose Metabolic Heterogeneity Correlates with Pathological Features and Improves Survival Stratification of Resectable Lung Adenocarcinoma.” Annals of Nuclear Medicine, vol. 37, Nov. 2022, pp. 139–50. EBSCOhost, https://doi.org/10.1007/s12149-022-01811-y.

APA

Yu-Hung Chen, Yen-Chang Chen, Kun-Han Lue, Sung-Chao Chu, Bee-Song Chang, Ling-Yi Wang, Ming-Hsun Li, & Chih-Bin Lin. (2022). Glucose metabolic heterogeneity correlates with pathological features and improves survival stratification of resectable lung adenocarcinoma. Annals of Nuclear Medicine, 37, 139–150. https://doi.org/10.1007/s12149-022-01811-y

Chicago

Yu-Hung Chen, Yen-Chang Chen, Kun-Han Lue, Sung-Chao Chu, Bee-Song Chang, Ling-Yi Wang, Ming-Hsun Li, and Chih-Bin Lin. 2022. “Glucose Metabolic Heterogeneity Correlates with Pathological Features and Improves Survival Stratification of Resectable Lung Adenocarcinoma.” Annals of Nuclear Medicine 37 (November): 139–50. doi:10.1007/s12149-022-01811-y.